| 1 | 2 | 3 | 4 | |
---|---|---|---|---|---|
Absorption | |||||
Blood–Brain Barrier | BBB +  | 0.5641 | 0.7761 | 0.783861 | 0.855371 |
Human Intestinal Absorption | HIA +  | 0.7199 | 0.863 | 0.763 | 0.8758 |
Caco-2 Permeability | Caco2- | 0.8307 | 0.8353 | 0.843653 | 0.920618 |
P-glycoprotein Substrate | Substrate | 0.5382 | 0.7801 | 0.787901 | 0.859779 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9377 | 0.8511 | 0.859611 | 0.938031 |
 | Non-inhibitor | 0.9639 | 0.781 | 0.78881 | 0.860771 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9307 | 0.8312 | 0.839512 | 0.916099 |
Subcellular localization | Mitochondria | 0.7339 | 0.8699 | 0.878599 | 0.958752 |
Aqueous solubility | Â | -3.144 | -4.3883 | -4.43218 | -4.83652 |
Caco-2 Permeability | Â | -0.076 | 1.5443 | 1.559743 | 1.702035 |
CYP450 2C9 Substrate | Non-substrate | 0.8339 | 0.8258 | 0.834058 | 0.910147 |
CYP450 2D6 Substrate | Non-substrate | 0.9096 | 0.8973 | 0.906273 | 0.98895 |
CYP450 3A4 Substrate | Non-substrate | 0.7205 | 0.7901 | 0.798001 | 0.870801 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5914 | 0.9169 | 0.926069 | 1.010552 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.5591 | 0.9071 | 0.916171 | 0.999751 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9575 | 0.9485 | 0.957985 | 1.04538 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8017 | 0.9025 | 0.911525 | 0.994681 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9078 | 0.8695 | 0.878195 | 0.958311 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9568 | 0.9046 | 0.913646 | 0.996996 |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9721 | 0.9582 | 0.967782 | 1.056071 |
 | Non-inhibitor | 0.9152 | 0.813 | 0.82113 | 0.89604 |
AMES Toxicity | Non-AMES toxic | 0.9127 | 0.849 | 0.85749 | 0.935717 |
Carcinogens | Non-carcinogens | 0.9582 | 0.9394 | 0.948794 | 1.03535 |
Fish Toxicity | High FHMT | 0.9615 | 0.9924 | 1.002324 | 1.093764 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9583 | 0.985 | 0.99485 | 1.085608 |
Honeybee Toxicity | High HBT | 0.5796 | 0.8437 | 0.852137 | 0.929876 |
Biodegradation | Not readily biodegradable | 0.8051 | 0.962 | 0.97162 | 1.060259 |
Acute Oral Toxicity | II | 0.602 | 0.8316 | 0.839916 | 0.91654 |
Carcinogenicity (Three-class) | Non-required | 0.6954 | 0.5962 | 0.602162 | 0.657096 |
Rat Acute Toxicity | Â | 2.6213 | 2.3902 | 2.414102 | 2.634335 |
Fish Toxicity | Â | 0.526 | 0.8147 | 0.822847 | 0.897913 |
Tetrahymena Pyriformis Toxicity | Â | 0.386 | 0.9588 | 0.968388 | 1.056732 |
Drug likeness | Â | 0 | 0 | 0 | 0 |
No. H-bond acceptors | Â | 3 | 3 | 3 | 3 |
No. H-bond donors | Â | 2 | 2 | 2 | 2 |
Fraction Csp3 | Saturation fraction | 0.9 | 0.9 | 0.909 | 0.991926 |
Molar reactivity | MR | 136.91 | 136.91 | 138.0165 | 150.6074 |
Topological surface area | TPSA | 57.53 | 57.53 | 58.1053 | 63.40611 |
Log P | Lipophilicity | 3.95 | 3.95 | 3.9794 | 4.342432 |
Log S | Solubility | -7.23 | -7.23 | -7.3932 | -7.06766 |
Lipinski No. violations | Â | 1 | 1 | 1 | 1 |
Ghose No. violations | Â | 3 | 3 | 3 | 3 |
Veber No. violations | Â | 0 | 0 | 0 | 0 |
Egan No. violations | Â | 1 | 1 | 1 | 1 |
Muegge No. violations | Â | 1 | 1 | 1 | 1 |
Bioavailability Score | Â | 0.85 | 0.85 | 0.85 | 0.853 |
PAINS #alerts | Â | 0 | 0 | 0 | 0 |
Brenk #alerts | Â | 1 | 1 | 1 | 1 |